Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessCorrection: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
-
Article
Open AccessCorrection to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
-
Article
Open AccessDiscovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
Non-small cell lung cancer (NSCLC) patients with activating EGFR mutations initially respond to first-generation EGFR inhibitors; however, the efficacy of these drugs is limited by acquired resistance driven b...